<DOC>
	<DOCNO>NCT00249444</DOCNO>
	<brief_summary>Many substance dependent individual also suffer depression . Past research suggest antidepressant medication helpful treating individual . This study determine effectiveness mirtazapine , antidepressant medication , treat cocaine dependent individual also suffer depression . This study include free treatment cocaine dependence include medication behavioral intervention .</brief_summary>
	<brief_title>Mirtazapine Treating Cocaine Dependent Individuals Who Also Suffer From Depression</brief_title>
	<detailed_description>Cocaine abuse depression often occur together . Individuals suffer usually able quit abuse cocaine . Past research conduct alcohol dependent individual also suffer depression show individual able successfully quit drink addition antidepressant medication . Mirtazapine medication currently use treat depression . This study evaluate efficacy mirtazapine , use combination behavioral therapy , treat cocaine dependent individual also suffer depression . Participants 8-week trial randomly assign receive either mirtazapine placebo . Prior start medication treatment , participant undergo initial 2-week phase consist psychosocial behavioral therapy . The purpose lead-in phase achieve initial reduction abstinence cocaine use , observe cocaine withdrawal symptom mood change associate depression . During first 2 week , participant attend three study visit week , time participate motivational interview cognitive behavioral relapse prevention therapy . During phase , participant successfully remain abstinent cocaine use reward high-value monetary voucher . Upon complete lead-in phase , participant randomly assign receive either mirtazapine placebo . Participants attend study visit twice week 8 week . Mood drug use evaluate study visit . Cognitive behavioral relapse prevention therapy continue throughout study . In addition , participant earn low-value monetary voucher contingent cocaine abstinence . At end Week 8 , participant enter lead-out phase . At time , participant whose mood significantly improve able continue treatment additional 8 week . Participants whose mood show improvement taper assigned medication treatment offer treatment alternative medication . Following completion lead-out phase , participant refer continue care community .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Mirtazapine</mesh_term>
	<mesh_term>Mianserin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Meets DSMIV criterion current cocaine dependence Currently seek treatment cocaine dependence Used cocaine least one day per 2week period month prior study entry Meets DSMIV criterion current major depression dysthymia syndrome Scores great 12 Baseline 21 Hamilton Depression Scale Ages 1860 Meets DSMIV criterion past mania ( e.g. , bipolar disorder ) , schizophrenia , psychotic disorder transient psychosis due drug abuse Scores le 11 Baseline 21 Hamilton Depression Scale History seizures History allergic reaction mirtazapine Chronic organic mental disorder Current suicidal risk history suicidal behavior Pregnant , breastfeeding , unwilling use adequate method contraception duration study Unstable physical disorder , include high blood pressure , acute hepatitis , diabetes Coronary vascular disease indicate history , suspect abnormal electrocardiogram , history cardiac symptom Cardiac conduction system disease , indicate electrocardiogram QRS duration great 0.11 History failure respond previous trial mirtazapine Currently take psychotropic medication Meets DSMIV criterion opioid sedativehypnotic dependence Meets DSMIV criterion alcohol dependence evidence clinically significant physiological dependence need medically supervise detoxification Current alcohol marijuana dependence identify main problem seek treatment ; individual alcohol marijuana dependence ( without significant physiological dependence ) cocaine dependence eligible , long cocaine identify primary substance problem seek treatment History neutropenia ( &lt; 500 granulocyte /cc ) Agranulocytosis ( &lt; 500 granulocytes/cc ) fever , infection . Concurrent intake medication possible neutropenic effect : chlorpromazine , carbamazepine , clozapine , chemotherapeutic drug , immunosuppressant medication , interferon , ganciclovir , protease inhibitor . Patients able meet attendance requirement 4/6 visit leadin period . Supplemental exclusion criterion cold pressor test ( CPT ) : history frostbite , open cut sore foot immerse , history Raynaud 's phenomenon . Supplemental exclusion criterion CPT : hypertension ( BP le equal 140/90 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>